You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半日速报》恒指半日收报29,718点 升76点; 恒生科技指数半日收报9,652点 升278点 美团升逾6% 友邦跌逾3% 美团、药明生物、申洲、翰森制药、龙源电力创新高
阿思达克 01-20 12:05
恒指半日收29,718点,升76点或0.3%。恒生科技指数报9,652点,升278点或3.0%。国指升87点或0.7%,报11,822点。

活跃重磅股表现:

美团(03690.HK) 收362.8元,上升6.4%,创新高;

友邦(01299.HK) 收105.4元,下跌3.2%;

腾讯(00700.HK) 收672元,上升2.6%;

阿里巴巴(09988.HK) 收249.8元,上升2.3%;

港交所(00388.HK) 收510元,上升1.8%;

平安(02318.HK) 收99.95元,下跌1.6%;

异动恒指及国指成份股:

阿里健康(00241.HK) 收25.8元,上升10%;

京东健康(06618.HK) 收161.2元,上升9%;

石药(01093.HK) 收8.96元,上升5.8%;

中国铁塔(00788.HK) 收1.23元,下跌4.7%;

中国海外发展(00688.HK) 收19.64元,上升4.6%;

中生制药(01177.HK) 收7.7元,上升4.5%;

中国恒大(03333.HK) 收16.58元,下跌3.9%;

联通(00762.HK) 收4.9元,下跌3.9%;

吉利(00175.HK) 收33.25元,上升3.9%;

太保(02601.HK) 收37.3元,下跌3.6%;

安踏(02020.HK) 收138.7元,下跌3.6%;

中国飞鹤(06186.HK) 收24.9元,上升3.5%;

港铁(00066.HK) 收43.7元,下跌3.4%;

药明生物(02269.HK) 收114.2元,上升3.1%,创新高;

申洲(02313.HK) 收155.3元,上升0.8%,创新高;

翰森制药(03692.HK) 收44.85元,上升0.4%,创新高;

异动综合中小型股:

龙源电力(00916.HK) 收12.66元,上升12.2%,创新高;

启明医疗(02500.HK) 收81.7元,上升12.1%;

中国船舶租赁(03877.HK) 收1.23元,上升11.8%;

耐世特(01316.HK) 收12.94元,上升11.6%;

康方生物(09926.HK) 收55.15元,上升11.5%,创新高;

四环医药(00460.HK) 收1.02元,上升10.9%;

FIT HON TENG(06088.HK) 收3.17元,上升10.5%;

~

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account